For the purposes of Iran GL N-1, covered COVID-19-related goods or technology include, for example: medical gowns; medical eye shields and goggles; surgical gloves; face shields; respirators and masks such as N95, N99, and N100 masks; personal hygiene products such as soap and hand sanitizer and other water, sanitation, and hygiene supplies such as: water purification supplies and hygiene promotion materials; vaccines and vaccine ingredients or components required for the production of vaccines; equipment, supplies, and containers for transporting, storing, and administering vaccines; COVID-19 testing kits and equipment, and software and technology for processing such kits; equipment, software, and technology for diagnostic imaging tests; ventilators or components thereof; oxygen tanks and supplies to deliver oxygen; supplies, medicines, or other therapies to treat COVID-19; and field hospitals or mobile medical units, provided that all conditions and limitations of Iran GL N-1 are satisfied, including with regard to the classification of certain goods and technology set forth in paragraph (d)(1) of Iran GL N-1. Certain COVID-19-related medical devices designated as EAR99 that would otherwise require a specific license for exportation or reexportation to Iran because they are included on OFAC’s List of Medical Devices Requiring Specific Authorization — such as High Efficiency Particulate Air (HEPA) Filtration Systems and HEPA filters — would not require a specific license for exportation or reexportation to Iran, provided that all conditions and limitations of Iran GL N-1 are satisfied.
Transactions and activities related to the exportation, reexportation, sale, or supply of such goods or technology include, for example: processing and transfer of funds; payment of taxes, fees, and import duties; purchase or receipt of permits, licenses, or public utility services; making of shipping and cargo inspection arrangements; obtaining of insurance; arrangement of financing and payment; shipping and storage of the goods; receipt of payment; and entry into contracts (including executory contracts), provided that all conditions and limitations of Iran GL N-1 are satisfied. Certain transactions and activities involving the Central Bank of Iran (CBI), the National Iranian Oil Company (NIOC), or any entity in which NIOC owns, directly or indirectly, a 50 percent or greater interest, are also authorized under Iran GL N-1.
As noted in Iran GL N-1, this general license does not authorize the unblocking of any property blocked pursuant to any part of 31 CFR chapter V, including property of the Government of Iran.
Updated: June 10, 2022